请输入关键字
请输入关键字
订购
*国家
中国
美国
中国香港
中国澳门
中国台湾
阿尔巴尼亚
阿尔及利亚
阿根廷
阿拉伯联合酋长国
阿鲁巴
阿曼
阿塞拜疆
阿森松岛
埃及
埃塞俄比亚
爱尔兰
爱沙尼亚
安道尔
安哥拉
安圭拉
安提瓜和巴布达
奥地利
奥兰群岛
澳大利亚
巴巴多斯
巴布亚新几内亚
巴哈马
巴基斯坦
巴拉圭
巴勒斯坦领土
巴林
巴拿马
巴西
白俄罗斯
百慕大
保加利亚
北马里亚纳群岛
贝宁
比利时
冰岛
波多黎各
波兰
波斯尼亚和黑塞哥维那
玻利维亚
伯利兹
博茨瓦纳
不丹
布基纳法索
布隆迪
朝鲜
赤道几内亚
丹麦
德国
迪戈加西亚岛
东帝汶
多哥
多米尼加共和国
多米尼克
俄罗斯
厄瓜多尔
厄立特里亚
法国
法罗群岛
法属波利尼西亚
法属圭亚那
法属南部领地
梵蒂冈
菲律宾
斐济
芬兰
佛得角
福克兰群岛
冈比亚
刚果(布)
刚果(金)
哥伦比亚
哥斯达黎加
格恩西岛
格林纳达
格陵兰
格鲁吉亚
古巴
瓜德罗普
关岛
圭亚那
哈萨克斯坦
海地
韩国
荷兰
荷属加勒比区
荷属圣马丁
黑山
洪都拉斯
基里巴斯
吉布提
吉尔吉斯斯坦
几内亚
几内亚比绍
加拿大
加纳
加纳利群岛
加蓬
柬埔寨
捷克
津巴布韦
喀麦隆
卡塔尔
开曼群岛
科科斯(基林)群岛
科摩罗
科索沃
科特迪瓦
科威特
克罗地亚
肯尼亚
库克群岛
库拉索
拉脱维亚
莱索托
老挝
黎巴嫩
立陶宛
利比里亚
利比亚
联合国
列支敦士登
留尼汪
卢森堡
卢旺达
罗马尼亚
马达加斯加
马恩岛
马尔代夫
马耳他
马拉维
马来西亚
马里
马其顿
马绍尔群岛
马提尼克
马约特
毛里求斯
毛里塔尼亚
美国本土外小岛屿
美属萨摩亚
美属维尔京群岛
蒙古
蒙特塞拉特
孟加拉国
秘鲁
密克罗尼西亚
缅甸
摩尔多瓦
摩洛哥
摩纳哥
莫桑比克
墨西哥
纳米比亚
南非
南极洲
南乔治亚和南桑威奇群岛
南苏丹
瑙鲁
尼加拉瓜
尼泊尔
尼日尔
尼日利亚
纽埃
挪威
诺福克岛
帕劳
皮特凯恩群岛
葡萄牙
日本
瑞典
瑞士
萨尔瓦多
萨摩亚
塞尔维亚
塞拉利昂
塞内加尔
塞浦路斯
塞舌尔
沙特阿拉伯
圣巴泰勒米
圣诞岛
圣多美和普林西比
圣赫勒拿
圣基茨和尼维斯
圣卢西亚
圣马丁岛
圣马力诺
圣皮埃尔和密克隆群岛
圣文森特和格林纳丁斯
斯里兰卡
斯洛伐克
斯洛文尼亚
斯瓦尔巴和扬马延
斯威士兰
苏丹
苏里南
所罗门群岛
索马里
塔吉克斯坦
泰国
坦桑尼亚
汤加
特克斯和凯科斯群岛
特里斯坦-达库尼亚群岛
特立尼达和多巴哥
突尼斯
图瓦卢
土耳其
土库曼斯坦
托克劳
瓦利斯和富图纳
瓦努阿图
危地马拉
委内瑞拉
文莱
乌干达
乌克兰
乌拉圭
乌兹别克斯坦
希腊
西班牙
西撒哈拉
新加坡
新喀里多尼亚
新西兰
匈牙利
休达及梅利利亚
叙利亚
牙买加
亚美尼亚
也门
伊拉克
伊朗
以色列
意大利
印度
印度尼西亚
英国
英属维尔京群岛
英属印度洋领地
约旦
越南
赞比亚
泽西岛
乍得
直布罗陀
智利
中非共和国
*省份
*城市
*姓名
*电话
*单位
*职位
*邮箱
*请输入验证码
*验证码
B-hCD16A mice
Strain Name
C57BL/6-Fcgr4tm2(FCGR3A)Bcgen/Bcgen 
Common Name  B-hCD16A mice
Background C57BL/6N Catalog number  111173
Related Genes 
FCGR3A (Fc fragment of IgG receptor IIIa), CD16A
NCBI Gene ID
246256

mRNA expression analysis


from clipboard


Strain specific analysis of CD16A gene expression in wild-type mice and homozygous B-hCD16A mice by RT-PCR. Mouse Fcgr4 mRNA was exclusively detectable in wild-type mice and human FCGR3A mRNA was exclusively detectable in homozygous B-hCD16A mice (H/H).


Protein expression analysis in NK cells


from clipboard


Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. 
Splenocytes were collected from wild-type C57BL/6 mice(+/+)  and homozygous B-hCD16A mice (H/H). Human CD16A was exclusively detectable in the NK cells of homozygous B-hCD16A mice.


Protein expression analysis in macrophages

from clipboard


Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. Peritoneal exudative macrophages(PEMs) were collected from wild-type C57BL/6 mice(+/+)  and homozygous B-hCD16A mice(H/H). Mouse CD16A was exclusively detectable in wild-type C57BL/6 mice. Human CD16A was exclusively detectable in homozygous B-hCD16A mice.


Protein expression analysis in multiple lymphocyte subtypes
NK cells

from clipboard


Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. 
Different tissues were collected from wild-type C57BL/6 mice(+/+)  and homozygous B-hCD16A mice (H/H). Human CD16A was exclusively detectable in the NK cells of homozygous B-hCD16A mice.


Granulocytes

from clipboard


Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. 
Different tissues were collected from wild-type C57BL/6 mice(+/+)  and homozygous B-hCD16A mice (H/H). Mouse CD16A was exclusively detective in granulocytes of wild-type mice. Human CD16A was not detectable in granulocytes of wild-type C57BL/6 mice or homozygous B-hCD16A mice.


Macrophages

from clipboard


Strain specific CD16A expression analysis in wild-type C57BL/6 mice and homozygous B-hCD16A mice by flow cytometry. Different tissues were collected from wild-type C57BL/6 mice(+/+)  and homozygous B-hCD16A mice (H/H). Mouse CD16A was exclusively detective in macrophages of wild-type mice. Human CD16A was exclusively detectable in macrophages of homozygous B-hCD16A mice .


Summary

from clipboard


Protein expression analysis in NK cells


from clipboard



Strain specific CD16A expression level analysis in NK cells of homozygous B-hCD16A mice and human PBMCs by flow cytometry.  


Analysis of leukocytes subpopulation in B-hCD16A  mice

from clipboard


Analysis of spleen leukocyte subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Analysis of spleen T cell subpopulations in B-hCD16A  mice

from clipboard


Analysis of spleen T cell subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old).  Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Analysis of leukocytes subpopulation in B-hCD16A  mice

from clipboard


Analysis of LNs leukocyte subpopulations by FACS. LNs were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the LNs was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Analysis of LNs T cell subpopulations in B-hCD16A  mice

from clipboard


Analysis of LNs T cell subpopulations by FACS. LNs were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old).  Flow cytometry analysis of the LNs was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Analysis of leukocytes subpopulation in B-hCD16A  mice

from clipboard


Analysis of blood leukocyte subpopulations by FACS. Blood were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old). Flow cytometry analysis of the blood was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Analysis of blood T cell subpopulations in B-hCD16A mice

from clipboard


Analysis of blood T cell subpopulations by FACS. Blood were isolated from female C57BL/6 and B-hCD16A mice (n=3, 6-week-old).  Flow cytometry analysis of the blood was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for TCRβ+T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Values are expressed as mean ± SEM.


Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells in B-hCD16A mice.

B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCLDN18.2 MC38 cells, B-hBCMA MC38 cells and B-hB7-H3 MC38 cells were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.


Tumor growth curve & Body weight changes



from clipboard


Subcutaneous homograft tumor growth of B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 in B-hCD16A mice. B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hEPCAM MC38 cells, B-hROR1 MC38 cells and B-hLILRB4 MC38 were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.


Tumor growth curve & Body weight changes


from clipboard

Subcutaneous homograft tumor growth of B-hCD19 MC38 cells and B-hTPBG MC38 in B-hCD16A mice. B-hCD19 MC38 cells, B-hTPBG MC38 (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD19 MC38 cells and B-hTPBG MC38 were able to establish tumors in B-hCD16A mice and can be used for efficacy studies.


Tumor growth curve & Body weight changes

from clipboard


Subcutaneous homograft tumor growth of B-hCLDN6 MC38 cells in B-hCD16A mice. B-hCLDN6 MC38 (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into B-hCD16A mice (female, 8-week-old, n=8). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCLDN6 MC38 cells was able to establish tumors in B-hCD16A mice and can be used for efficacy studies.


Antitumor activity of anti-human CD16A-based Ab in B-hCD16A mice 


from clipboard


Antitumor activity of anti-human CD16A-based Ab in B-hCD16A mice. (A) Anti-human CD16A-based Ab inhibited MC38 tumor growth in B-hCD16A mice. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-hCD16A mice (female,13 week-old, n=7). Mice were grouped when tumor volume reached approximately 70 mm3, at which time they were treated with anti-human CD16A-based Ab with doses and schedules indicated in panel B. (B) Body weight changes during treatment. As shown in panel A, anti-human CD16A-based Ab was efficacious in controlling tumor growth in B-hCD16A mice, demonstrating that the B-hCD16A mice provide a powerful preclinical model for in vivo evaluation of anti-human CD16A-based Ab. Values are expressed as mean ± SEM.